Free the flow

Introducing the world’s first wire-free intraplaque crossing and one-step vessel preparation platform

Discover AtheroplastyTM Innovation 

INTRAPLAQUE ATHEROPLASTY

Three Mechanisms.
One Interface.
Unlimited Potential.

SantrevaTM-ATK

Wire-free crossing, intraplaque compression and channel formation – in a single step with minimal risk of embolism, flow-limiting dissection, or major perforation in severely stenotic lesions, including CTOs1 – welcome to the new era in endovascular revascularization.

SantrevaTM-ATK

Wire-free crossing, intraplaque compression and channel formation – in a single step with minimal risk of embolism, flow-limiting dissection, or major perforation in severely stenotic lesions, including CTOs1 – welcome to the new era in endovascular revascularization.

RESTOR-1 Pivotal Trial Key Findings

Revascularization Confirmed.
Simplification Accomplished.

Confirming revascularization in trial results showed strong evidence in support of Atheroplasty.1

~ 0 %
Overall Success
> 0 %
Mean Lumen Gain2
0
Device-Related MAEs
See the Clinical Evidence
1RESTOR-1 Pivotal Clinical Study, data on file and Instructions for Use (IFU)
2Post hoc analysis of prospectively collected data, as assessed by the core lab: data on file with company

From Proximal Cap to True Lumen
Introducing Santreva-ATK

Santreva-ATK is an all-in-one, large-profile, manually controlled, and guidewire-free endovascular CTO crossing solution, with full force range and control to tackle the wide range of plaque morphologies, designed to limit damage to the vessel wall.